☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Teva
Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of N...
October 17, 2023
Insights+: The US FDA New Drug Approvals in May 2023
June 22, 2023
Teva and MedinCell Receive the US FDA’s Approval of Uzedy (risperidone) Extended-Release Injectable Suspension for Schizophrenia
May 1, 2023
Teva's Partner Alvotech Receives Complete Response Letter on the BLA of AVT02 (biosimilar, adalimumab)
April 14, 2023
Teva’s Austedo XR (deutetrabenazine) Extended-Release Tablets Receives the US FDA’s Approval for Tardive Dyskinesia and Chorea Ass...
February 17, 2023
Teva Reports 3-Year (ARC-HD) Study Results of Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington’s...
October 19, 2022
Load more...
Back to Home